Uncertain future of trials in osteoporosis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12107656.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The advent of effective agents for the treatment of osteoporosis has led to the view that placebo-controlled trials to test new agents for efficacy are no longer appropriate since proven treatments are available. In this review we argue that, if new agents are to be developed, there is still a place for the placebo-controlled trial. A move to studies of equivalence or non-inferiority raises more problems than it resolves.
Medical subject headings
- Clinical Trials as Topic
- Ethics, Medical
- Osteoporosis